文献速递临床试验与 GCP

低潮气量通气策略对无ARDS的ICU患者无呼吸机天数的影响:一项随机临床试验

Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

该随机临床试验纳入荷兰6个ICU中无ARDS且预计插管后24小时内不能拔管的961例患者,比较低潮气量与中等潮气量通气策略。结果显示两组第28天无呼吸机天数中位数均为21天,差异无统计学意义;ICU住院时间、住院时间、28天及90天死亡率、ARDS、肺炎、严重肺不张或气胸发生率均无显著差异。

要点

  • 在无ARDS且预计24小时内不能拔管的ICU患者中,低潮气量通气未比中等潮气量通气增加第28天无呼吸机天数。
  • 两组在ICU住院时间、住院时间、28天及90天死亡率上均无显著差异。
  • 两组ARDS、肺炎、严重肺不张或气胸的发生率均无显著差异。

核心结论

  • 对于无ARDS且预计插管后24小时内不能拔管的ICU患者,低潮气量通气策略未比中等潮气量策略带来更多无呼吸机天数。

研究设计与样本

  • 随机临床试验,2014年9月1日至2017年8月20日在荷兰6个ICU进行。
  • 共纳入961例无ARDS且预计开始通气后24小时内不能拔管的患者。
  • 低潮气量组477例,中等潮气量组484例。

临床怎么用

  • 对于无ARDS且预计短期不能拔管的ICU患者,低潮气量通气未显示优于中等潮气量通气,临床决策需结合个体情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: It remains uncertain whether invasive ventilation should use low tidal volumes in critically ill patients without acute respiratory distress syndrome (ARDS). OBJECTIVE: To determine whether a low tidal volume ventilation strategy is more effective than an intermediate tidal volume strategy. DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial, conducted from September 1, 2014, through August 20, 2017, including patients without ARDS expected to not be extubated within 24 hours after start of ventilation from 6 intensive care units in the Netherlands. INTERVENTIONS: Invasive ventilation using low tidal volumes (n = 477) or intermediate tidal volumes (n = 484). MAIN OUTCOMES AND MEASURES: The primary outcome was the number of ventilator-free days and alive at day 28. Secondary outcomes included length of ICU and hospital stay; ICU, hospital, and 28- and 90-day mortality; and development of ARDS, pneumonia, severe atelectasis, or pneumothorax. RESULTS: In total, 961 patients (65% male), with a median age of 68 years (interquartile range [IQR], 59-76), were enrolled. At day 28, 475 patients in the low tidal volume group had a median of 21 ventilator-free days (IQR, 0-26), and 480 patients in the intermediate tidal volume group had a median of 21 ventilator-free days (IQR, 0-26) (mean difference, -0.27 [95% CI, -1.74 to 1.19]; P = .71). There was no significant difference in ICU (median, 6 vs 6 days; 0.39 [-1.09 to 1.89]; P = .58) and hospital (median, 14 vs 15 days; -0.60 [-3.52 to 2.31]; P = .68) length of stay or 28-day (34.9% vs 32.1%; hazard ratio [HR], 1.12 [0.90 to 1.40]; P = .30) and 90-day (39.1% vs 37.8%; HR, 1.07 [0.87 to 1.31]; P = .54) mortality. There was no significant difference in the percentage of patients developing the following adverse events: ARDS (3.8% vs 5.0%; risk ratio [RR], 0.86 [0.59 to 1.24]; P = .38), pneumonia (4.2% vs 3.7%; RR, 1.07 [0.78 to 1.47]; P = .67), severe atelectasis (11.4% vs 11.2%; RR, 1.00 [0.81 to 1.23]; P = .94), and pneumothorax (1.8% vs 1.3%; RR, 1.16 [0.73 to 1.84]; P = .55). CONCLUSIONS AND RELEVANCE: In patients in the ICU without ARDS who were expected not to be extubated within 24 hours of randomization, a low tidal volume strategy did not result in a greater number of ventilator-free days than an intermediate tidal volume strategy. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02153294.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Simonis FD, Serpa Neto A, Binnekade JM, et al. Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial. JAMA. 2018. PMID: 30357256. doi:10.1001/jama.2018.14280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。